<VariationArchive VariationID="2011853" VariationName="NM_000702.4(ATP1A2):c.524del (p.Lys175fs)" VariationType="Deletion" Accession="VCV002011853" Version="2" RecordType="classified" NumberOfSubmissions="1" NumberOfSubmitters="1" DateLastUpdated="2024-02-20" DateCreated="2023-02-08" MostRecentSubmission="2024-02-20">
  <RecordStatus>current</RecordStatus>
  <Species>Homo sapiens</Species>
  <ClassifiedRecord>
    <SimpleAllele AlleleID="2067230" VariationID="2011853">
      <GeneList>
        <Gene Symbol="ATP1A2" FullName="ATPase Na+/K+ transporting subunit alpha 2" GeneID="477" HGNC_ID="HGNC:800" Source="submitted" RelationshipType="within multiple genes by overlap">
          <Location>
            <CytogeneticLocation>1q23.2</CytogeneticLocation>
            <SequenceLocation Assembly="GRCh38" AssemblyAccessionVersion="GCF_000001405.38" AssemblyStatus="current" Chr="1" Accession="NC_000001.11" start="160115759" stop="160143591" display_start="160115759" display_stop="160143591" Strand="+" />
            <SequenceLocation Assembly="GRCh37" AssemblyAccessionVersion="GCF_000001405.25" AssemblyStatus="previous" Chr="1" Accession="NC_000001.10" start="160085519" stop="160113380" display_start="160085519" display_stop="160113380" Strand="+" />
          </Location>
          <OMIM>182340</OMIM>
        </Gene>
        <Gene Symbol="LOC126805890" FullName="CDK7 strongly-dependent group 2 enhancer GRCh37_chr1:160093987-160095186" GeneID="126805890" Source="calculated" RelationshipType="within multiple genes by overlap">
          <Location>
            <CytogeneticLocation>1q23.2</CytogeneticLocation>
            <SequenceLocation Assembly="GRCh38" AssemblyAccessionVersion="GCF_000001405.38" AssemblyStatus="current" Chr="1" Accession="NC_000001.11" start="160124197" stop="160125396" display_start="160124197" display_stop="160125396" Strand="+" />
          </Location>
        </Gene>
      </GeneList>
      <Name>NM_000702.4(ATP1A2):c.524del (p.Lys175fs)</Name>
      <CanonicalSPDI>NC_000001.11:160124322:AA:A</CanonicalSPDI>
      <VariantType>Deletion</VariantType>
      <Location>
        <CytogeneticLocation>1q23.2</CytogeneticLocation>
        <SequenceLocation Assembly="GRCh38" AssemblyAccessionVersion="GCF_000001405.38" forDisplay="true" AssemblyStatus="current" Chr="1" Accession="NC_000001.11" start="160124323" stop="160124323" display_start="160124323" display_stop="160124323" variantLength="1" positionVCF="160124322" referenceAlleleVCF="GA" alternateAlleleVCF="G" />
        <SequenceLocation Assembly="GRCh37" AssemblyAccessionVersion="GCF_000001405.25" AssemblyStatus="previous" Chr="1" Accession="NC_000001.10" start="160094113" stop="160094113" display_start="160094113" display_stop="160094113" variantLength="1" positionVCF="160094112" referenceAlleleVCF="GA" alternateAlleleVCF="G" />
      </Location>
      <ProteinChange>K175fs</ProteinChange>
      <HGVSlist>
        <HGVS Type="genomic">
          <NucleotideExpression sequenceAccessionVersion="LRG_6" sequenceAccession="LRG_6">
            <Expression>LRG_6:g.13567del</Expression>
          </NucleotideExpression>
        </HGVS>
        <HGVS Type="coding">
          <NucleotideExpression sequenceAccessionVersion="LRG_6t1" sequenceAccession="LRG_6t1">
            <Expression>LRG_6t1:c.524del</Expression>
          </NucleotideExpression>
          <ProteinExpression sequenceAccessionVersion="LRG_6p1" sequenceAccession="LRG_6p1" change="p.Lys175Argfs">
            <Expression>LRG_6p1:p.Lys175Argfs</Expression>
          </ProteinExpression>
        </HGVS>
        <HGVS Assembly="GRCh37" Type="genomic, top-level">
          <NucleotideExpression sequenceAccessionVersion="NC_000001.10" sequenceAccession="NC_000001" sequenceVersion="10" change="g.160094114del" Assembly="GRCh37">
            <Expression>NC_000001.10:g.160094114del</Expression>
          </NucleotideExpression>
        </HGVS>
        <HGVS Assembly="GRCh38" Type="genomic, top-level">
          <NucleotideExpression sequenceAccessionVersion="NC_000001.11" sequenceAccession="NC_000001" sequenceVersion="11" change="g.160124324del" Assembly="GRCh38">
            <Expression>NC_000001.11:g.160124324del</Expression>
          </NucleotideExpression>
        </HGVS>
        <HGVS Type="genomic">
          <NucleotideExpression sequenceAccessionVersion="NG_008014.1" sequenceAccession="NG_008014" sequenceVersion="1" change="g.13567del">
            <Expression>NG_008014.1:g.13567del</Expression>
          </NucleotideExpression>
        </HGVS>
        <HGVS Type="genomic">
          <NucleotideExpression sequenceAccessionVersion="NG_082214.1" sequenceAccession="NG_082214" sequenceVersion="1" change="g.228del">
            <Expression>NG_082214.1:g.228del</Expression>
          </NucleotideExpression>
        </HGVS>
        <HGVS Type="coding">
          <NucleotideExpression sequenceAccessionVersion="NM_000702.4" sequenceAccession="NM_000702" sequenceVersion="4" change="c.524del" MANESelect="true">
            <Expression>NM_000702.4:c.524del</Expression>
          </NucleotideExpression>
          <ProteinExpression sequenceAccessionVersion="NP_000693.1" sequenceAccession="NP_000693" sequenceVersion="1" change="p.Lys175fs">
            <Expression>NP_000693.1:p.Lys175fs</Expression>
          </ProteinExpression>
          <MolecularConsequence ID="SO:0001589" Type="frameshift variant" DB="SO" />
        </HGVS>
      </HGVSlist>
    </SimpleAllele>
    <RCVList>
      <RCVAccession Title="NM_000702.4(ATP1A2):c.524del (p.Lys175fs) AND Familial hemiplegic migraine" Accession="RCV002838723" Version="2">
        <ClassifiedConditionList TraitSetID="16855">
          <ClassifiedCondition DB="MedGen" ID="C0338484">Familial hemiplegic migraine</ClassifiedCondition>
        </ClassifiedConditionList>
        <RCVClassifications>
          <GermlineClassification>
            <ReviewStatus>criteria provided, single submitter</ReviewStatus>
            <Description DateLastEvaluated="2022-06-28" SubmissionCount="1">Pathogenic</Description>
          </GermlineClassification>
        </RCVClassifications>
      </RCVAccession>
    </RCVList>
    <Classifications>
      <GermlineClassification DateLastEvaluated="2022-06-28" NumberOfSubmissions="1" NumberOfSubmitters="1" DateCreated="2023-02-08" MostRecentSubmission="2024-02-20">
        <ReviewStatus>criteria provided, single submitter</ReviewStatus>
        <Description>Pathogenic</Description>
        <Citation Type="general">
          <ID Source="PubMed">30690204</ID>
        </Citation>
        <ConditionList>
          <TraitSet ID="16855" Type="Disease" ContributesToAggregateClassification="true">
            <Trait ID="9495" Type="Disease">
              <Name>
                <ElementValue Type="Preferred">Familial hemiplegic migraine</ElementValue>
                <XRef ID="Familial+Hemiplegic+Migraine/9656" DB="Genetic Alliance" />
                <XRef ID="MONDO:0000700" DB="MONDO" />
                <XRef ID="95656000" DB="SNOMED CT" />
              </Name>
              <AttributeSet>
                <Attribute Type="public definition">Familial hemiplegic migraine (FHM) falls within the category of migraine with aura. In migraine with aura (including FHM) the neurologic symptoms of aura are unequivocally localizable to the cerebral cortex or brain stem and include visual disturbance (most common), sensory loss (e.g., numbness or paresthesias of the face or an extremity), and dysphasia (difficulty with speech). FHM must include motor involvement, such as hemiparesis (weakness of an extremity). Hemiparesis occurs with at least one other symptom during FHM aura. Neurologic deficits with FHM attacks can be prolonged for hours to days and may outlast the associated migrainous headache. FHM is often earlier in onset than typical migraine, frequently beginning in the first or second decade; the frequency of attacks tends to decrease with age. Approximately 40%-50% of families with CACNA1A-FHM have cerebellar signs ranging from nystagmus to progressive, usually late-onset mild ataxia.</Attribute>
                <XRef ID="NBK1388" DB="GeneReviews" />
              </AttributeSet>
              <Citation Type="review" Abbrev="GeneReviews">
                <ID Source="PubMed">20301562</ID>
                <ID Source="BookShelf">NBK1388</ID>
              </Citation>
              <Citation Type="practice guideline" Abbrev="Orphanet, 2013">
                <URL>https://www.orpha.net/data/patho/Pro/en/Emergency_HemiplegicMigraine-enPro1031.pdf</URL>
                <CitationText>Orphanet, Hemiplegic Migraine (HM), 2013</CitationText>
              </Citation>
              <XRef ID="C0338484" DB="MedGen" />
              <XRef ID="MONDO:0000700" DB="MONDO" />
              <XRef Type="Phenotypic series" ID="PS141500" DB="OMIM" />
            </Trait>
          </TraitSet>
        </ConditionList>
      </GermlineClassification>
    </Classifications>
    <ClinicalAssertionList>
      <ClinicalAssertion ID="5905113" SubmissionDate="2024-02-08" DateLastUpdated="2024-02-20" DateCreated="2023-02-07">
        <ClinVarSubmissionID localKey="16987516|MedGen:C0338484" submittedAssembly="GRCh37" />
        <ClinVarAccession Accession="SCV003212261" DateUpdated="2024-02-20" DateCreated="2023-02-07" Type="SCV" Version="2" SubmitterName="Invitae" OrgID="500031" OrganizationCategory="laboratory" OrgAbbreviation="Invitae" />
        <RecordStatus>current</RecordStatus>
        <Classification DateLastEvaluated="2022-06-28">
          <ReviewStatus>criteria provided, single submitter</ReviewStatus>
          <GermlineClassification>Pathogenic</GermlineClassification>
          <Citation>
            <ID Source="PubMed">30690204</ID>
          </Citation>
          <Comment>For these reasons, this variant has been classified as Pathogenic. This variant has not been reported in the literature in individuals affected with ATP1A2-related conditions. This variant is not present in population databases (gnomAD no frequency). This sequence change creates a premature translational stop signal (p.Lys175Argfs*17) in the ATP1A2 gene. It is expected to result in an absent or disrupted protein product. Loss-of-function variants in ATP1A2 are known to be pathogenic (PMID: 30690204).</Comment>
        </Classification>
        <Assertion>variation to disease</Assertion>
        <AttributeSet>
          <Attribute Type="AssertionMethod">Invitae Variant Classification Sherloc (09022015)</Attribute>
          <Citation>
            <ID Source="PubMed">28492532</ID>
          </Citation>
        </AttributeSet>
        <ObservedInList>
          <ObservedIn>
            <Sample>
              <Origin>germline</Origin>
              <Species TaxonomyId="9606">human</Species>
              <AffectedStatus>unknown</AffectedStatus>
            </Sample>
            <Method>
              <MethodType>clinical testing</MethodType>
            </Method>
            <ObservedData>
              <Attribute Type="Description">not provided</Attribute>
            </ObservedData>
          </ObservedIn>
        </ObservedInList>
        <SimpleAllele>
          <GeneList>
            <Gene Symbol="ATP1A2" />
          </GeneList>
          <VariantType>Variation</VariantType>
          <AttributeSet>
            <Attribute Type="HGVS">NC_000001.10:g.160094113del</Attribute>
          </AttributeSet>
        </SimpleAllele>
        <TraitSet Type="Disease">
          <Trait Type="Disease">
            <XRef DB="MedGen" ID="C0338484" Type="CUI" />
          </Trait>
        </TraitSet>
        <SubmissionNameList>
          <SubmissionName>SUB12507860</SubmissionName>
          <SubmissionName>SUB14200279</SubmissionName>
        </SubmissionNameList>
      </ClinicalAssertion>
    </ClinicalAssertionList>
    <TraitMappingList>
      <TraitMapping ClinicalAssertionID="5905113" TraitType="Disease" MappingType="XRef" MappingValue="C0338484" MappingRef="MedGen">
        <MedGen CUI="C0338484" Name="Familial hemiplegic migraine" />
      </TraitMapping>
    </TraitMappingList>
  </ClassifiedRecord>
</VariationArchive>

